Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000719135-23-000033
Filing Date
2023-06-23
Accepted
2023-06-23 09:15:17
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A apyx-20230623.htm   iXBRL DEF 14A 828996
6 apyx-20230623_g1.jpg GRAPHIC 80972
7 apyx-20230623_g2.jpg GRAPHIC 57418
  Complete submission text file 0000719135-23-000033.txt   1690445

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apyx-20230623.xsd EX-101.SCH 4266
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apyx-20230623_def.xml EX-101.DEF 3845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apyx-20230623_lab.xml EX-101.LAB 8714
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apyx-20230623_pre.xml EX-101.PRE 5297
10 EXTRACTED XBRL INSTANCE DOCUMENT apyx-20230623_htm.xml XML 104266
Mailing Address 5115 ULMERTON ROAD CLEARWATER FL 33760
Business Address 5115 ULMERTON ROAD CLEARWATER FL 33760 7273842323
Apyx Medical Corp (Filer) CIK: 0000719135 (see all company filings)

EIN.: 112644611 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31885 | Film No.: 231035046
SIC: 3841 Surgical & Medical Instruments & Apparatus